share_log

醫渡科技:2023/2024 中期報告

YIDU TECH: 2023/2024 Interim Report

香港交易所 ·  Dec 28, 2023 03:32
Summary by Moomoo AI
醫渡科技有限公司(Yidu Tech Inc.),一家於開曼群島註冊成立的有限公司,公布了2023/24年度中期報告。報告顯示,公司在大數據平台和解決方案、生命科學解決方案以及健康管理平台和解決方案三大業務板塊均實現毛利率提升。期間虧損大幅縮窄至人民幣7,956萬元,同比下降77.7%,經調整淨虧損為人民幣5,410萬元,同比縮窄75.9%。截至2023年9月30日,集團在手訂單金額為人民幣8.72億元,同比增長58.0%。報告期內,公司未派發任何股息,並於報告期後無重大期後事件。
醫渡科技有限公司(Yidu Tech Inc.),一家於開曼群島註冊成立的有限公司,公布了2023/24年度中期報告。報告顯示,公司在大數據平台和解決方案、生命科學解決方案以及健康管理平台和解決方案三大業務板塊均實現毛利率提升。期間虧損大幅縮窄至人民幣7,956萬元,同比下降77.7%,經調整淨虧損為人民幣5,410萬元,同比縮窄75.9%。截至2023年9月30日,集團在手訂單金額為人民幣8.72億元,同比增長58.0%。報告期內,公司未派發任何股息,並於報告期後無重大期後事件。
Yidu Tech Inc. (Yidu Tech Inc.) , a Cayman Islands-registered limited company, has published its Interim Report for 2023/24. The report showed that the company achieved gross margin gains in the Big Data Platform and Solutions, Life Science Solutions, and Health Management Platforms and Solutions business segments. The loss for the period narrowed sharply to RMB7,956 million, down 77.7% year-on-year, and an adjusted net loss of RMB5,410 million, a year-on-year decrease of 75.9%. As of September 30, 2023, the Group's total order amount was RMB8.72 billion, an increase of 58.0% year-on-year. During the reporting period, the company did not pay any dividends and there were no significant after-events after the reporting period.
Yidu Tech Inc. (Yidu Tech Inc.) , a Cayman Islands-registered limited company, has published its Interim Report for 2023/24. The report showed that the company achieved gross margin gains in the Big Data Platform and Solutions, Life Science Solutions, and Health Management Platforms and Solutions business segments. The loss for the period narrowed sharply to RMB7,956 million, down 77.7% year-on-year, and an adjusted net loss of RMB5,410 million, a year-on-year decrease of 75.9%. As of September 30, 2023, the Group's total order amount was RMB8.72 billion, an increase of 58.0% year-on-year. During the reporting period, the company did not pay any dividends and there were no significant after-events after the reporting period.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more